First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer

Por Vaccaro, Vanja, Bria, Emilio, Sperduti, Isabella, Gelibter, Alain, Moscetti, Luca, Mansueto, Giovanni, Ruggeri, Enzo Maria, Gamucci, Teresa, Cognetti, Francesco, Milella, Michele
Publicado em 2013

Metastatic pancreatic cancer: Is there a light at the end of the tunnel?

Por Vaccaro, Vanja, Sperduti, Isabella, Vari, Sabrina, Bria, Emilio, Melisi, Davide, Garufi, Carlo, Nuzzo, Carmen, Scarpa, Aldo, Tortora, Giampaolo, Cognetti, Francesco, Reni, Michele, Milella, Michele
Publicado no World J Gastroenterol (2015)

Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials

Por Loupakis, Fotios, Bria, Emilio, Vaccaro, Vanja, Cuppone, Federica, Milella, Michele, Carlini, Paolo, Cremolini, Chiara, Salvatore, Lisa, Falcone, Alfredo, Muti, Paola, Sperduti, Isabella, Giannarelli, Diana, Cognetti, Francesco
Publicado em 2010

PTEN: Multiple Functions in Human Malignant Tumors

Por Milella, Michele, Falcone, Italia, Conciatori, Fabiana, Cesta Incani, Ursula, Del Curatolo, Anais, Inzerilli, Nicola, Nuzzo, Carmen M. A., Vaccaro, Vanja, Vari, Sabrina, Cognetti, Francesco, Ciuffreda, Ludovica
Publicado no Front Oncol (2015)

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma,...

Por Carbognin, Luisa, Pilotto, Sara, Milella, Michele, Vaccaro, Vanja, Brunelli, Matteo, Caliò, Anna, Cuppone, Federica, Sperduti, Isabella, Giannarelli, Diana, Chilosi, Marco, Bronte, Vincenzo, Scarpa, Aldo, Bria, Emilio, Tortora, Giampaolo
Publicado no PLoS One (2015)

Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials

Por Cuppone, Federica, Bria, Emilio, Giannarelli, Diana, Vaccaro, Vanja, Milella, Michele, Nisticò, Cecilia, Ruggeri, Enzo Maria, Sperduti, Isabella, Bracarda, Sergio, Pinnarò, Paola, Lanzetta, Gaetano, Muti, Paola, Cognetti, Francesco, Carlini, Paolo
Publicado em 2010

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Por Russillo Michelangelo, Nisticò Cecilia, Milella Michele, Carlini Paolo, Sperduti Isabella, Fabi Alessandra, Puglisi Fabio, Vaccaro Vanja, Bria Emilio, Cuppone Federica, Papaldo Paola, Ferretti Gianluigi, Aapro Matti, Giannarelli Diana, Cognetti Francesco
Publicado em 2011-05-01

Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials

Por Cuppone, Federica, Bria, Emilio, Vaccaro, Vanja, Puglisi, Fabio, Fabi, Alessandra, Sperduti, Isabella, Carlini, Paolo, Milella, Michele, Nisticò, Cecilia, Russillo, Michelangelo, Papaldo, Paola, Ferretti, Gianluigi, Aapro, Matti, Giannarelli, Diana, Cognetti, Francesco
Publicado em 2011